Programmed cell death-1, or PD-1, has become a headline-grabbing molecule best known for its role in cancer immunotherapies ...

From early development to old age, cell death is a part of life. Without enough of a critical type of cell death known as ...

Researchers from the National Defense Medical Center in Taiwan have identified an increased risk of psoriasis in patients ...

The mechanisms underlying skin renewal are still poorly understood. Interleukin-38 (IL-38), a protein involved in regulating ...

The following is a summary of "Phase II Trial of Enfortumab Vedotin in Patients With Previously Treated Advanced Head and ...

Keytruda is a biologic that belongs to the programmed cell death protein 1 (PD-1) inhibitor drug class. Read on to learn about potential common, mild, and serious side effects of Keytruda.

First, it activates the protein BID, which directly destroys the mitochondria, leading to cell death. Simultaneously, caspase-2 activates the well-known tumor suppressor p53, which initiates ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and LaNova Medicines Ltd. (LaNova), a privately held ...

Minghui Pharmaceutical has reported promising initial outcomes from its Phase I trial of MHB039A to treat patients with ...

Gotistobart is a next-generation anti-cytotoxic T-lymphocyte-associated protein 4 antibody candidate ... despite prior treatment with a programmed cell death protein 1 or programmed death ligand ...